Summary
Sean Hannifin is a PhD candidate in Immunology at the University of Michigan investigating how hypoxia shapes interactions between tumor cells, fibroblasts, and tumor-associated macrophages to drive pancreatic cancer. With nine years of research experience spanning NCI, Penn State, and UVA, he pairs deep translational science with hands-on nanoliposome and immune-agonist work. Sean is building biotech business acumen through roles at Nucleate, MassBio, and fellowships in biomedical innovation and affordability, and now consults and manages projects at miLEAD Consulting to bridge lab discoveries to market. Based in Ann Arbor, he brings a rare blend of wet-lab expertise and strategy for early-stage therapeutics and diagnostics, and outside the lab composes music and writes fantasy, signaling creative problem-solving beyond the bench.
9 years of coding experience
2 years of employment as a software developer
Master of Science - MS, Bioengineering and Biomedical Engineering, Master of Science - MS, Bioengineering and Biomedical Engineering at Penn State University
Doctor of Philosophy - PhD, Immunology, Doctor of Philosophy - PhD, Immunology at U-M Program in Biomedical Sciences (PIBS)
Bachelor of Science - BS, Bioengineering and Biomedical Engineering, Bachelor of Science - BS, Bioengineering and Biomedical Engineering at University of Virginia